Claire Soudais
Claire Soudais
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
1,2,✉,
Romane Schaus
Romane Schaus
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
1,
Camille Bachelet
Camille Bachelet
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
1,2,
Norbert Minet
Norbert Minet
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
1,2,
Sara Mouasni
Sara Mouasni
3Laboratory of Molecular Basis of Altered Immune Homeostasis Inserm UMR 1163, Institut Imagine, Paris, France
3,
Cécile Garcin
Cécile Garcin
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
1,2,
Caique Lopes Souza
Caique Lopes Souza
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
1,2,
Pierre David
Pierre David
4Transgenesis Platform, Laboratoire d’Expérimentation Animale et Transgenèse (LEAT), Institut Imagine-Structure Fédérative de Recherche Necker INSERM US24/CNRS, Paris, France
4,
Clara Cousu
Clara Cousu
5Université Paris Cité, CNRS UMR 8253, INSERM U1151, Institut Necker Enfants Malades, Paris, France
5,
Hélène Asnagli
Hélène Asnagli
6Step-Pharma, Technoparc du Pays-de-Gex, Saint-Genis-Pouilly, France
6,
Andrew Parker
Andrew Parker
6Step-Pharma, Technoparc du Pays-de-Gex, Saint-Genis-Pouilly, France
6,
Paul Palmquist-Gomes
Paul Palmquist-Gomes
2Université de Paris Cité, Paris, France
7Imagine - Institut Pasteur, Unit of Heart Morphogenesis, INSERM UMR1163, Paris, France
2,7,
Fernando E Sepulveda
Fernando E Sepulveda
3Laboratory of Molecular Basis of Altered Immune Homeostasis Inserm UMR 1163, Institut Imagine, Paris, France
3,
Sébastien Storck
Sébastien Storck
5Université Paris Cité, CNRS UMR 8253, INSERM U1151, Institut Necker Enfants Malades, Paris, France
5,
Sigolène M Meilhac
Sigolène M Meilhac
2Université de Paris Cité, Paris, France
7Imagine - Institut Pasteur, Unit of Heart Morphogenesis, INSERM UMR1163, Paris, France
2,7,
Alain Fischer
Alain Fischer
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
8Collège de France, Paris, France
1,8,#,
Emmanuel Martin
Emmanuel Martin
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
1,#,
Sylvain Latour
Sylvain Latour
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
1,2,✉
1Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
2Université de Paris Cité, Paris, France
3Laboratory of Molecular Basis of Altered Immune Homeostasis Inserm UMR 1163, Institut Imagine, Paris, France
4Transgenesis Platform, Laboratoire d’Expérimentation Animale et Transgenèse (LEAT), Institut Imagine-Structure Fédérative de Recherche Necker INSERM US24/CNRS, Paris, France
5Université Paris Cité, CNRS UMR 8253, INSERM U1151, Institut Necker Enfants Malades, Paris, France
6Step-Pharma, Technoparc du Pays-de-Gex, Saint-Genis-Pouilly, France
7Imagine - Institut Pasteur, Unit of Heart Morphogenesis, INSERM UMR1163, Paris, France
8Collège de France, Paris, France
Subject terms: Lymphocytes, Immunological disorders
© The Author(s) 2025
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
